Literature DB >> 25022589

Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis.

Zhijian Zhang1, Yufeng Wang2, Yu Pang3, Changting Liu4.   

Abstract

We compared the efficiencies of different drug susceptibility testing methods in detecting rifampin (RIF) heteroresistance in Mycobacterium tuberculosis. Our data revealed that the broth dilution method found more resistance than MGIT did (P=0.046) for the low-resistance group. Similarly, the broth dilution method was more sensitive in detecting RIF heteroresistance in subpopulations with low growth rates than was MGIT (P=0.033). In conclusion, our data demonstrated that the broth dilution method was more sensitive than MGIT in detecting RIF heteroresistance.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25022589      PMCID: PMC4135805          DOI: 10.1128/AAC.02778-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

Authors:  Neel R Gandhi; Paul Nunn; Keertan Dheda; H Simon Schaaf; Matteo Zignol; Dick van Soolingen; Paul Jensen; Jaime Bayona
Journal:  Lancet       Date:  2010-05-22       Impact factor: 79.321

Review 2.  Population biological principles of drug-resistance evolution in infectious diseases.

Authors:  Pia Abel zur Wiesch; Roger Kouyos; Jan Engelstädter; Roland R Regoes; Sebastian Bonhoeffer
Journal:  Lancet Infect Dis       Date:  2011-03       Impact factor: 25.071

3.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  National survey of drug-resistant tuberculosis in China.

Authors:  Yanlin Zhao; Shaofa Xu; Lixia Wang; Daniel P Chin; Shengfen Wang; Guanglu Jiang; Hui Xia; Yang Zhou; Qiang Li; Xichao Ou; Yu Pang; Yuanyuan Song; Bing Zhao; Hongtao Zhang; Guangxue He; Jing Guo; Yu Wang
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

Review 5.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Borna Müller; Sonia Borrell; Graham Rose; Sebastien Gagneux
Journal:  Trends Genet       Date:  2012-12-13       Impact factor: 11.639

6.  Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.

Authors:  Yu Pang; Jie Lu; Yufeng Wang; Yuanyuan Song; Shengfen Wang; Yanlin Zhao
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

7.  Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results.

Authors:  A Van Deun; L Barrera; I Bastian; L Fattorini; H Hoffmann; K M Kam; L Rigouts; S Rüsch-Gerdes; A Wright
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

8.  Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan.

Authors:  J Suo; C E Chang; T P Lin; L B Heifets
Journal:  Am Rev Respir Dis       Date:  1988-10

9.  Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China.

Authors:  Yu Pang; Yang Zhou; Bing Zhao; Guan Liu; Guanglu Jiang; Hui Xia; Yuanyuan Song; Yuanyuan Shang; Shengfen Wang; Yan-lin Zhao
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

10.  Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.

Authors:  Halima M Said; Marleen M Kock; Nazir A Ismail; Kamaldeen Baba; Shaheed V Omar; Ayman G Osman; Anwar A Hoosen; Marthie M Ehlers
Journal:  BMC Infect Dis       Date:  2012-12-22       Impact factor: 3.090

View more
  16 in total

1.  Misdiagnosis of tuberculosis associated with some species of nontuberculous mycobacteria by GeneXpert MTB/RIF assay.

Authors:  Yu Pang; Jie Lu; Biyi Su; Huiwen Zheng; Yanlin Zhao
Journal:  Infection       Date:  2017-07-13       Impact factor: 3.553

2.  Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.

Authors:  John Z Metcalfe; Elizabeth Streicher; Grant Theron; Rebecca E Colman; Christopher Allender; Darrin Lemmer; Rob Warren; David M Engelthaler
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

3.  Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system.

Authors:  Y Tan; B Su; H Zheng; Y Wang; Y Pang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-20       Impact factor: 3.267

Review 4.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633

5.  Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.

Authors:  Urvashi B Singh; Pooja Pandey; Girija Mehta; Anuj K Bhatnagar; Anant Mohan; Vinay Goyal; Vineet Ahuja; Ranjani Ramachandran; Kuldeep S Sachdeva; Jyotish C Samantaray
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

6.  Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Authors:  Phelim Bradley; N Claire Gordon; Timothy M Walker; Laura Dunn; Simon Heys; Bill Huang; Sarah Earle; Louise J Pankhurst; Luke Anson; Mariateresa de Cesare; Paolo Piazza; Antonina A Votintseva; Tanya Golubchik; Daniel J Wilson; David H Wyllie; Roland Diel; Stefan Niemann; Silke Feuerriegel; Thomas A Kohl; Nazir Ismail; Shaheed V Omar; E Grace Smith; David Buck; Gil McVean; A Sarah Walker; Tim E A Peto; Derrick W Crook; Zamin Iqbal
Journal:  Nat Commun       Date:  2015-12-21       Impact factor: 14.919

7.  A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.

Authors:  Elena Y Nosova; Danila V Zimenkov; Anastasia A Khakhalina; Alexandra I Isakova; Ludmila Y Krylova; Marina V Makarova; Ksenia Y Galkina; Maria A Krasnova; Svetlana G Safonova; Vitaly I Litvinov; Dmitry A Gryadunov; Elena M Bogorodskaya
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

8.  Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, China: A Retrospective Study.

Authors:  Jidong Guo; Rongmei Liu; Jin Shi; Fengmin Huo; Yuanyuan Shang; Fen Wang; Mengqiu Gao; Shanshan Li
Journal:  Infect Drug Resist       Date:  2021-07-06       Impact factor: 4.003

9.  Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study.

Authors:  Rebecca E Colman; Julia Anderson; Darrin Lemmer; Erik Lehmkuhl; Sophia B Georghiou; Hannah Heaton; Kristin Wiggins; John D Gillece; James M Schupp; Donald G Catanzaro; Valeriu Crudu; Ted Cohen; Timothy C Rodwell; David M Engelthaler
Journal:  J Clin Microbiol       Date:  2016-05-25       Impact factor: 5.948

10.  Dependence of Xpert MTB/RIF Accuracy for Detecting Rifampin Resistance in Bronchoalveolar Lavage Fluid on Bacterial Load: A Retrospective Study in Beijing, China.

Authors:  Lin Qin; Fengmin Huo; Weicong Ren; Yuanyuan Shang; Cong Yao; Xuxia Zhang; Rongmei Liu; Liping Ma; Mengqiu Gao; Yu Pang
Journal:  Infect Drug Resist       Date:  2021-06-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.